" 558.355 
monensin. 
(a) specifications. type a medicated articles containing monensin, usp. 
(b) approvals. approvals for type a medicated articles containing the specified levels of monensin activity granted to firms identified by sponsor numbers in  510.600(c) of this chapter for the conditions of use indicated in paragraph (f) of this section are as follows: 
(1) to no. 000986: 36.3 (for export only), 44, 45, 60, or 90.7 grams per pound for use as in paragraphs (f)(1)(i) and (f)(4) of this section. 
(2) to 000986: 110 grams per lb., paragraphs (f)(1) (i), (iii), (iv), (v), (ix), and (x). 
(3) [reserved] 
(4) to no. 000986: 45, 60, or 90.7 grams per pound for use as in paragraph (f)(2) of this section. 
(5) to 066104: 45 and 60 grams per pound, as monensin sodium provided by no. 000986, paragraphs (f)(1)(xiii), (xx), and (xxi) of this section. 
(6) to no. 000986: 45, 60, or 90.7 grams per pound for use as in paragraph (f)(5) of this section. 
(7) to 000986: 20, 30, 45, 60, 80, and 90.7 grams per pound, as monensin sodium, paragraph (f)(3) of this section. 
(8) to 054771: 45 and 60 grams per pound, as monensin sodium provided by no. 000986, paragraph (f)(1)(xiv) of this section. 
(9) to 054771: 45 and 60 grams per pound, as monensin sodium provided by no. 000986, paragraphs (f)(1)(xv) and (xvi) of this section. 
(10) to 016592: 45 and 60 grams per pound, as monensin sodium, paragraph (f)(1)(xvii) of this section. 
(11) to 054771: 45 and 60 grams per pound, as monensin sodium provided by no. 000986, paragraphs (f)(1)(xiv), (xviii), (xix), (xxiii), (xxiv), (xxv), (xxvi), and (xxvii) of this section. 
(12) to 066104: 45 and 60 grams per pound, as monensin sodium provided by no. 000986, paragraph (f)(1)(xxii) of this section. 
(13) to no. 012286: 60 and 80 grams per pound, paragraph (f)(3)(v) of this section. 
(14) to 000986: 60, 80, and 90.7 grams per pound, as monensin sodium, paragraph (f)(6) of this section. 
(c) [reserved] 
(d) special considerations. (1) type c chicken feed containing monensin as the mycelial cake shall bear an expiration date of 90 days after its date of manufacture. 
(2)-(3) [reserved] 
(4) liquid type b feeds shall bear an expiration date of 8 weeks after its date of manufacture. 
(5) all type a medicated articles containing monensin shall bear the following warning statement: when mixing and handling monensin type a medicated articles, use protective clothing, impervious gloves, and a dust mask. operators should wash thoroughly with soap and water after handling. if accidental eye contact occurs, immediately rinse thoroughly with water. 
(6) all formulations containing monensin shall bear the following caution statement: do not allow horses or other equines access to feed containing monensin. ingestion of monensin by horses has been fatal. 
(7) type a medicated articles containing monensin intended for use in cattle and goats shall bear, in addition to the caution statement in paragraph (d)(6) of this section, the following statements: 
(i) monensin medicated cattle and goat feeds are safe for use in cattle and goats only. consumption by unapproved species may result in toxic reactions. 
(ii) feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. 
(iii) must be thoroughly mixed in feeds before use. 
(iv) do not feed undiluted. 
(v) do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. 
(vi) do not feed to lactating goats. 
(vii) if feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing (see paragraphs (d)(10)(i) and (d)(10)(ii) of this section). 
(viii) a withdrawal period has not been established for this product in pre-ruminating calves. do not use in calves to be processed for veal. 
(ix) you may notice the following: reduced voluntary feed intake in dairy cows fed monensin. this reduction increases with higher doses of monensin fed. rule out monensin as the cause of reduced feed intake before attributing to other causes such as illness, feed management, or the environment. reduced milk fat percentage in dairy cows fed monensin. this reduction increases with higher doses of monensin fed. increased incidence of cystic ovaries and metritis in dairy cows fed monensin. reduced conception rates, increased services per animal, and extended days open and corresponding calving intervals in dairy cows fed monensin. have a comprehensive and ongoing nutritional, reproductive, and herd health program in place when feeding monensin to dairy cows. 
(x) inadequate mixing (recirculation or agitation) of monensin liquid type b or type c medicated feeds has resulted in increased monensin concentration which has been fatal to cattle and could be fatal to goats. 
(8) type a medicated articles containing monensin intended for use in chickens, turkeys, and quail shall bear the following statements: 
(i) do not allow horses, other equines, mature turkeys, or guinea fowl access to feed containing monensin. ingestion of monensin by horses and guinea fowl has been fatal. 
(ii) must be thoroughly mixed in feeds before use. 
(iii) do not feed undiluted. 
(iv) do not feed to laying chickens. 
(v) do not feed to chickens over 16 weeks of age. 
(vi) for replacement chickens intended for use as cage layers only. 
(vii) some strains of turkey coccidia may be monensin tolerant or resistant. monensin may interfere with development of immunity to turkey coccidiosis. 
(viii) in the absence of coccidiosis in broiler chickens the use of monensin with no withdrawal period may limit feed intake resulting in reduced weight gain. 
(9) type b feeds containing monensin shall bear the statements specified in the following paragraphs of this section when intended for use in: 
(i) cattle (as described in paragraphs (f)(3)(i) through (f)(3)(xii) of this section) : see paragraphs (d)(6), (d)(7)(i) through (d)(7)(v), (d)(7)(vii), and (d)(7)(viii) of this section. 
(ii) dairy cows (as described in paragraphs (f)(3)(xiii) and (f)(3)(xiv) of this section) : see paragraphs (d)(6), (d)(7)(i) through (d)(7)(iv), (d)(7)(vii), (d)(7)(viii), and (d)(7)(ix) of this section. 
(iii) goats : see paragraphs (d)(6) and (d)(7)(i) through (d)(7)(vi) of this section. 
(iv) chickens : see paragraphs (d)(8)(i) through (d)(8)(vi), and (d)(8)(viii) of this section. 
(v) turkeys: see paragraphs (d)(8)(i), (d)(8)(ii), (d)(8)(iii), and (d)(8)(vii) of this section. 
(vi) quail : see paragraphs (d)(8)(i), (d)(8)(ii), and (d)(8)(iii) of this section. 
(10) type c feeds containing monensin shall bear the statements specified in the following paragraphs of this section when intended for use in: 
(i) cattle (as described in paragraphs (f)(3)(i) through (f)(3)(xii) of this section): see paragraphs (d)(6), (d)(7)(i), (d)(7)(v), (d)(7)(vii), and (d)(7)(viii) of this section. paragraph (d)(7)(vii) of this section does not apply to free-choice type c medicated feeds as defined in  510.455 of this chapter. 
(ii) dairy cows (as described in paragraphs (f)(3)(xiii) and (f)(3)(xiv) of this section): see paragraphs (d)(6), (d)(7)(i), (d)(7)(vii), (d)(7)(viii), and (d)(7)(ix) of this section. paragraph (d)(7)(vii) of this section does not apply to free-choice type c medicated feeds as defined in  510.455 of this chapter. 
(iii) goats : see paragraphs (d)(6), (d)(7)(i), (d)(7)(v), and (d)(7)(vi) of this section. 
(iv) chickens : see paragraphs (d)(8)(i), (d)(8)(iv), (d)(8)(v), (d)(8)(vi), and (d)(8)(viii) of this section. 
(v) turkeys : see paragraphs (d)(8)(i) and (d)(8)(vii) of this section. 
(vi) quail : see paragraph (d)(8)(i) of this section. 
(11) type b and type c liquid feeds requiring recirculation or agitation that contain monensin and are intended for use in cattle (including dairy cows) and goats shall bear the caution statement specified in paragraph (d)(7)(x) of this section. 
(12) mixing directions for liquid feeds requiring recirculation or agitation: 
(i) for liquid feeds stored in recirculating tank systems: recirculate immediately prior to use for not less than 10 minutes, moving not less than 1 percent of the tank contents per minute from the bottom of the tank to the top. recirculate daily as described even when not used. 
(ii) for liquid feeds stored in mechanical, air, or other agitation-type tank systems: agitate immediately prior to use for not less than 10 minutes, creating a turbulence at the bottom of the tank that is visible at the top. agitate daily as described even when not used. 
(e) related tolerances. see  556.420 of this chapter. 
(f) conditions of use. it is used as follows: 
(1) broiler chickens (i) amount per ton. monensin, 90-110 grams. 
indications for use. as an aid in the prevention of coccidiosis caused by e. necatrix, e. tenella, e. acervulina, e. brunetti, e. mivati, and e. maxima. 
limitations. feed continuously as the sole ration. in the absence of coccidiosis, the use of monensin with no withdrawal period may limit feed intake resulting in reduced weight gain. do not feed to laying chickens. 
(ii) [reserved] 
(iii) amount per ton. monensin, 90-110 grams plus bacitracin, 5-25 grams. 
indications for use. for increased rate of weight gain and improved feed efficiency; as an aid in the prevention of coccidiosis caused by e. necatrix, e. tenella, e. acervulina, e. brunetti, e. mivati, and e. maxima. 
limitations. do not feed to laying chickens; feed continuously as sole ration; in the absence of coccidiosis, the use of monensin with no withdrawal period may limit feed intake resulting in reduced weight gain; as bacitracin methylene disalicylate provided by no. 054771 in  510.600(c) of this chapter; as monensin sodium. 
(iv) amount per ton. monensin, 90-110 grams plus bacitracin, 10 grams. 
indications for use. for increased rate of weight gain and improved feed efficiency; as an aid in the prevention of coccidiosis caused by e. necatrix, e. tenella, e. acervulina, e. brunetti, e. mivati, and e. maxima. 
limitations. do not feed to laying chickens; feed continuously as sole ration; in the absence of coccidiosis, the use of monensin with no withdrawal period may limit feed intake resulting in reduced weight gain; as zinc bacitracin provided by no. 054771 in  510.600(c) of this chapter; as monensin sodium. 
(v) amount per ton. monensin, 90-110 grams plus bacitracin, 10-30 grams. 
indications for use. for improved feed efficiency; as an aid in the prevention of coccidiosis caused by e. necatrix, e. tenella, e. acervulina, e. brunetti, e. mivati, and e. maxima. 
limitations. do not feed to laying chickens; feed continuously as sole ration; in the absence of coccidiosis, the use of monensin with no withdrawal period may limit feed intake resulting in reduced weight gain; as zinc bacitracin provided by no. 054771 in  510.600(c) of this chapter; as monensin sodium. 
(vi) amount per ton. monensin, 90 to 110 grams; plus bambermycins, 1 to 2 grams. 
indications for use. for increased rate of weight gain and improved feed efficiency; and as an aid in the prevention of coccidiosis caused by e. necatrix e. tenella e. acervulina e. brunetti e. mivati , and e. maxima. 
limitations. feed continuously as sole ration; do not feed to laying chickens. bambermycins provided by no. 016592 in  510.600(c) of this chapter. 
(vii) [reserved] 
(viii) amount per ton. monensin, 90 to 110 grams plus oxytetracycline, 200 grams. 
indications for use. as an aid in the prevention of coccidiosis caused by eimeria necatrix, e. tenella, e. acervulina, e. brunetti, e. mivati, and e. maxima; and for the control of complicated chronic respiratory disease (crd or air-sac infection) caused by mycoplasma gallisepticum and escherichia coli. 
limitations. in the absence of coccidiosis, the use of monensin with no withdrawal period may limit feed intake resulting in reduced weight gain; do not feed to laying chickens; feed continuously as sole ration; as monensin sodium. 
(ix) amount per ton. monensin, 90-110 grams plus lincomycin, 2 grams. 
indications for use. for increase in rate of weight gain and improved feed efficiency; as an aid in the prevention of coccidiosis caused by e. necatrix, e. tenella, e. acervulina, e. brunetti, e. mivati, and e. maxima. 
limitations. do not feed to laying chickens; to be fed as a sole ration; in the absence of coccidiosis, the use of monensin with no withdrawal period may limit feed intake resulting in reduced weight gain; as monensin sodium. 
(x)-(xii) [reserved] 
(xiii) amount per ton. monensin, 90 to 110 grams, plus 5 grams virginiamycin. 
indications for use. as an aid in the prevention of coccidiosis caused by e. necatrix, e. tenella, e. acervulina, e. brunetti, e. maxima, and e. mivati; for increased rate of weight gain and improved feed efficiency. 
limitations. do not feed to laying chickens; feed continuously as sole ration; as monensin sodium provided by no. 000986 in  510.600 of this chapter; virginiamycin provided by no. 066104 in  510.600 of this chapter. 
(xiv) amount per ton. monensin, 90 to 110 grams, plus 500 grams chlortetracycline. 
indications for use. as an aid in the reduction of mortality due to escherichia coli infections susceptible to such treatment. as an aid in the prevention of coccidiosis caused by eimeria necatrix, e. tenella, e. acervulina, e. brunetti, e. mivati, and e. maxima. 
limitations. do not feed to laying chickens; feed for 5 days as the sole ration; withdraw 24 hours before slaughter; in the absence of coccidiosis, the use of monensin with no withdrawal period may limit feed intake resulting in reduced weight gain; not to be fed continuously for more than 5 days; as monensin sodium; as chlortetracycline hydrochloride provided by nos. 054771 and 069254 in  510.600(c) of this chapter. 
(xv)-(xx) [reserved] 
(xxi) amount per ton. monensin, 90 to 110 grams, plus virginiamycin, 5 to 15 grams. 
indications for use. for increase in rate of weight gain; as an aid in the prevention of coccidiosis caused by eimeria necatrix, e. tenella, e. acervulina, e. maxima, e. brunetti, and e. mivati. 
limitations. do not feed to laying chickens; feed continuously as sole ration; as monensin sodium provided by no. 000986 in  510.600 of this chapter; virginiamycin provided by no. 066104 in  510.600 of this chapter. 
(xxii) amount per ton. monensin, 90 to 110 grams plus oxytetracycline, 500 grams. 
indications for use. as an aid in the prevention of coccidiosis caused by eimeria necatrix, e. tenella, e. acervulina, e. brunetti, e. mivati, and e. maxima; as an aid in the reduction of mortality due to air-sacculities (air-sac infection) caused by escherichia coli sensitive to oxytetracycline. 
limitations. feed for 5 days as sole ration. do not feed to laying chickens. withdraw 24 hours before slaughter. as monensin sodium provided by no. 000986 in  510.600(c) of this chapter. as mono-alkyl (c -c 18 ) trimethylammonium oxytetracycline provided by no. 066104 in  510.600(c) of this chapter. 
(xxiii) [reserved] 
(xxiv) amount per ton. monensin, 90 to 110 grams, plus bacitracin methylene disalicylate, 4 to 50 grams. 
(xxv) amount per ton. monensin, 90 to 110 grams plus bacitracin, 4 to 50 grams. 
indications for use. for increased rate of weight gain and improved feed efficiency; as an aid in the prevention of coccidiosis caused by eimeria necatrix, e. tenella, e. acervulina, e. brunetti, e. mivati, and e. maxima. 
limitations. do not feed to laying chickens; feed continuously as sole ration; in the absence of coccidiosis, the use of monensin with no withdrawal period may limit feed intake resulting in reduced weight gain; as bacitracin zinc provided by no. 054771 in  510.600(c) of this chapter, as monensin sodium. 
(xxvi)-(xxvii) [reserved] 
(xxviii) amount per ton. monensin, 90 to 110 grams, plus tylosin phosphate, 4 to 50 grams. 
indications for use. as an aid in the prevention of coccidiosis caused by eimeria necatrix, e. tenella, e. acervulina, e. brunetti, e. mivati, and e. maxima, for increased rate of weight gain, and improved feed efficiency. 
limitations. feed continuously as sole ration. in the absence of coccidiosis, the use of monensin with no withdrawal period may limit feed intake resulting in reduced weight gain. do not feed to laying chickens. as monensin sodium and tylosin phosphate provided by no. 000986 in  510.600(c) of this chapter. 
(xxix) amount per ton. monensin, 90 to 110 grams; plus bacitracin methylene disalicylate, 50 grams. 
indications for use. as an aid in the prevention of coccidiosis caused by e. necatrix, e. tenella, e. acervulina, e. brunetti, e. mivati, and e. maxima ; and as an aid in the prevention of necrotic enteritis caused or complicated by clostridium spp. or other organisms susceptible to bacitracin. 
limitations. feed continuously as sole ration. do not feed to chickens over 16 weeks of age. do not feed to laying chickens. as monensin sodium provided by 000986; bacitracin methylene disalicylate as provided by 054771 in  510.600(c) of this chapter. 
(xxx) amount per ton. monensin, 90 to 110 grams; plus bacitracin methylene disalicylate, 100 to 200 grams. 
indications for use. as an aid in the prevention of coccidiosis caused by e. necatrix, e. tenella, e. acervulina, e. brunetti, e. mivati, and e. maxima ; and as an aid in the control of necrotic enteritis caused or complicated by clostridium spp. or other organisms susceptible to bacitracin. 
limitations. feed continuously as sole ration. do not feed to chickens over 16 weeks of age. do not feed to laying chickens. to control necrotic enteritis, start medication at first clinical signs of disease; vary dosage based on the severity of infection; administer continuously for 5 to 7 days or as long as clinical signs persist, then reduce bacitracin to prevention level (50 grams per ton). as monensin sodium provided by 000986; bacitracin methylene disalicylate as provided by 054771 in  510.600(c) of this chapter. 
(xxxi) amount per ton. monensin, 90 to 110 grams; plus virginiamycin, 20 grams. 
indications for use. broiler chickens: as an aid in the prevention of coccidiosis caused by e. necatrix, e. tenella, e. acervulina, e. brunetti, e. mivati, and e. maxima; and for prevention of necrotic enteritis caused by clostridium perfringens susceptible to virginiamycin. 
limitations. feed continuously as sole ration. do not feed to laying chickens. see paragraph (d) of this section. as monensin provided by no. 000986; virginiamycin as provided by no. 066104 in  510.600(c) of this chapter. 
(2) turkeys (i) amount per ton. monensin, 54 to 90 grams. 
indications for use. for the prevention of coccidiosis in turkeys caused by e. adenoeides, e. meleagrimitis, and e. gallopavonis. 
limitations. for growing turkeys only; as monensin sodium; feed continuously as sole ration. do not allow horses, other equines, mature turkeys, or guinea fowl access to feed containing monensin. ingestion of monensin by horses and guinea fowl has been fatal. some strains of turkey coccidia may be monensin tolerant or resistant. monensin may interfere with development of immunity to turkey coccidiosis. 
(ii) amount per ton. monensin, 54 to 90 grams, and bacitracin methylene disalicylate, 4 to 50 grams. 
indications for use. for prevention of coccidiosis caused by eimeria adenoeides, e. meleagrimitis, and e. gallopavonis, for increased rate of weight gain, and for improved feed efficiency. 
limitations. for growing turkeys only; as monensin sodium; feed continuously as sole ration. do not allow horses, other equines, mature turkeys or guinea fowl access to feed containing monensin. ingestion of monensin by horses and guinea fowl has been fatal. some strains of turkey coccidia may be monensin tolerant or resistant. monensin may interfere with development of immunity to turkey coccidiosis. bacitracin methylene disalicylate as provided by no. 054771 in  510.600(c) of this chapter. 
(iii) amount per ton. monensin, 54 to 90 grams, and bacitracin methylene disalicylate, 200 grams. 
indications for use. for the prevention of coccidiosis caused by eimeria adenoides, e. meleagrimitis, and e. gallopavonis, and as an aid in the control of transmissible enteritis complicated by organisms susceptible to bacitracin methylene disalicylate. 
limitations. for growing turkeys only; as monensin sodium; feed continuously as sole ration. do not allow horses, other equines, mature turkeys or guinea fowl access to feed containing monensin. ingestion of monensin by horses and guinea fowl has been fatal. some strains of turkey coccidia may be monensin tolerant or resistant. monensin may interfere with development of immunity to turkey coccidiosis. bacitracin methylene disalicylate as provided by no. 054771 in  510.600(c) of this chapter. 
(iv) amount per ton. monensin, 54 to 90 grams, with virginiamycin, 10 to 20 grams. 
indications for use. for the prevention of coccidiosis caused by eimeria adenoeides, e. meleagrimitis, and e. gallopavonis, and for increased rate of weight gain and improved feed efficiency in growing turkeys. 
limitations. for growing turkeys only. feed continuously as sole ration. do not allow horses, other equines, mature turkeys, or guinea fowl access to feed containing monensin. ingestion of monensin by horses, mature turkeys, and guinea fowl has been fatal. some strains of turkey coccidia may be monensin tolerant or resistant. monensin may interfere with development of immunity to turkey coccidiosis. virginiamycin as provided by no. 066104 in  510.600(c) of this chapter. 
(v) amount per ton. monensin, 54 to 90 grams, plus bambermycins, 1 to 2 grams. 
indications for use. for the prevention of coccidiosis in turkeys caused by e. adenoeides, e. meleagrimitis, and e. gallopavonis, and for improved feed efficiency in growing turkeys. 
limitations. for growing turkeys only. feed continuously as sole ration. some strains of turkey coccidia may be monensin tolerant or resistant. monensin may interfere with development of immunity to turkey coccidiosis. bambermycins as provided by no. 016592 in  510.600(c) of this chapter. 
(vi) amount per ton. monensin, 54 to 90 grams, plus bambermycins, 2 grams. 
indications for use. for the prevention of coccidiosis in turkeys caused by e. adenoeides, e. meleagrimitis, and e. gallopavonis, and for increased rate of weight gain and improved feed efficiency in growing turkeys. 
limitations. for growing turkeys only. feed continuously as sole ration. some strains of turkey coccidia may be monensin tolerant or resistant. monensin may interfere with development of immunity to turkey coccidiosis. bambermycins as provided by no. 016592 in  510.600(c) of this chapter. 
(3) cattle (i) amount per ton. monensin, 5-40 grams. 
indications for use. improved feed efficiency. 
limitations. ) feed only to cattle being fed in confinement for slaughter. feed continuously in complete feed at a rate of 50 to 480 milligrams of monensin per head per day. no additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 grams per ton (360 milligrams per head per day). complete feeds may be manufactured from monensin liquid type b feeds. the liquid type b feeds have a ph of 4.3 to 7.1 and their labels must bear appropriate mixing directions as defined in paragraph (d)(12) of this section. the liquid feed must bear caution statement as follows: inadequate mixing, (recirculation or agitation), of liquid feeds has resulted in increased monensin concentration which has been fatal to cattle. 
) an approved physically stable monensin liquid feed will not be subject to the requirements for mixing directions defined in paragraph (d)(12) of this section. a manufacturer may secure approval of a physically stable liquid feed by: 
) either filing an nada for the product or by establishing a master file containing data to support the stability of its product; 
ii ) authorizing the agency to reference and rely upon the data in the master file to support approval of a supplemental nada to establish physical stability; and 
iii ) requesting no. 000986 in  510.600(c) of this chapter to file a supplemental nada to provide for the use of its monensin type a article in the manufacture of the liquid feed specified in the appropriate master file. if the data demonstrate the stability of the liquid feed described in the master file, the agency will approve the supplemental nada. the approval will provide a basis for the individual liquid feed manufacturer to manufacture the liquid medicated feed under a medicated feed mill license described in the master file. a manufacturer who seeks to market a physically unstable monensin liquid feed with mixing directions different from the standard established in paragraph (d)(12) of this section may also follow this procedure. 
(ii) amount per ton. monensin, 5 to 40 grams; plus tylosin, 8 to 10 grams. 
indications for use. cattle fed in confinement for slaughter: for improved feed efficiency; and reduction of incidence of liver abscesses caused by fusobacterium necrophorum and arcanobacterium (actinomyces) pyogenes. 
limitations. feed only to cattle being fed in confinement for slaughter. feed continuously as sole ration at the rate of 50 to 480 milligrams of monensin and 60 to 90 milligrams of tylosin per head per day. combination drug liquid type b medicated feeds may be used to manufacture dry type c medicated feeds and shall conform to mixing instructions as in 558.625(c) of this chapter. tylosin provided by nos. 000986 and 016592 in  510.600(c) of this chapter. 
(iii) amount per ton. monensin, 15 to 400 grams. 
indications for use. growing cattle on pasture or in dry lot (stocker and feeder cattle and dairy and beef replacement heifers): for increased rate of weight gain; for prevention and control of coccidiosis due to eimeria bovis and e. zuernii. 
limitations. for increased rate of weight gain, feed at a rate of 50 to 200 milligrams monensin per head per day in not less than 1 pound of feed or, after the 5th day, feed at a rate of 400 milligrams per head per day every other day in not less than 2 pounds of feed. for prevention and control of coccidiosis, feed at a rate of 0.14 to 0.42 milligram per pound of body weight per day, depending on severity of challenge, up to 200 milligrams per head per day. during first 5 days of feeding, cattle should receive no more than 100 milligrams per day in not less than 1 pound of feed. 
(iv) amount. monensin at concentrations in free-choice type c medicated feeds to provide 50 to 200 mg per head per day. 
indications for use. growing cattle on pasture or in dry lot (stocker and feeder cattle and dairy and beef replacement heifers): for increased rate of weight gain; for prevention and control of coccidiosis due to eimeria bovis and e. zuernii. 
limitations. during the first 5 days of feeding, cattle should receive no more than 100 milligrams per day. do not feed additional salt or minerals. do not mix with grain or other feeds. monensin is toxic to cattle when consumed at higher than approved levels. stressed and/or feed- and/or water-deprived cattle should be adapted to the pasture and to unmedicated supplement before using the monensin medicated supplement. the product's effectiveness in cull cows and bulls has not been established. see paragraph (d) of this section for other required label warnings. 
(v) [reserved] 
(vi) amount per ton. monensin, 25 to 400 grams. 
indications for use. for improved feed efficiency; for prevention and control of coccidiosis due to e. bovis and e. zuernii. 
limitations. feed to mature reproducing beef cows. feed as supplemental feed, either hand-fed in a minimum of 1 pound of feed or mixed in a total ration. for improved feed efficiency, feed continuously at a rate of 50 to 200 milligrams monensin per head per day. for prevention and control of coccidiosis, feed at a rate of 0.14 to 0.42 milligram per pound of body weight per day, depending upon severity of challenge, up to a maximum of 200 milligrams per head per day. during first 5 days of feeding, cattle should receive no more than 100 milligrams per head per day. 
(vii) amount per ton. monensin, 10 to 40 grams. 
indications for use. for prevention and control of coccidiosis due to e. bovis and e. zuernii. 
limitations. for cattle fed in confinement for slaughter, feed at a rate of 0.14 to 0.42 milligram per pound of body weight per day, depending upon the severity of challenge, up to maximum of 480 milligrams per head per day. 
(viii)-(ix) [reserved] 
(x) amount per ton. 1,620 grams monensin, usp. 
indications for use. growing cattle on pasture or in dry lot (stocker and feeder cattle and dairy and beef replacement heifers): for increased rate of weight gain; for prevention and control of coccidiosis due to eimeria bovis and e. zuernii. 
specifications. use as free-choice type c medicated feed formulated as mineral granules as follows: 
ingredient percent international feed no. monocalcium phosphate (21% phosphorus, 15% calcium) 29.49 6-01-082 sodium chloride (salt) 24.37 6-04-152 dried cane molasses 20.0 4-04-695 ground limestone (33% calcium) or calcium carbonate (38% calcium) 13.75 6-02-632 cane molasses 3.0 4-04-696 processed grain by-products (as approved by aafco) 5.0 vitamin/trace mineral premix 2.5 monensin type a article, 90.7 grams per pound 0.89 antidusting oil 1.0 content of the vitamin/trace mineral premix may be varied. however, they should be comparable to those used for other free-choice feeds. formulation modifications require fda approval prior to marketing. the amount of selenium and ethylenediamine dihydroiodide (eddi) must comply with the published requirements. (for selenium see 21 cfr 573.920; for eddi see 51 fr 11483 (april 3, 1986).) 
limitations. feed at a rate of 50 to 200 milligrams per head per day. during the first 5 days of feeding, cattle should receive no more than 100 milligrams per day. do not feed additional salt or minerals. do not mix with grain or other feeds. monensin is toxic to cattle when consumed at higher than approved levels. stressed and/or feed- and/or water-deprived cattle should be adapted to the pasture and to unmedicated mineral supplement before using the monensin mineral supplement. the product's effectiveness in cull cows and bulls has not been established. 
(xi) amount per ton. monensin, 10 to 200 grams. 
indications for use. for prevention and control of coccidiosis due to e. bovis and e. zuernii. 
limitations. for calves excluding veal calves. feed at a rate of 0.14 to 1.0 milligram monensin per pound of body weight per day, depending upon the severity of challenge, up to maximum of 200 milligrams per head per day. 
(xii) amount per ton. monensin, 10 to 40 grams; plus tylosin, 8 to 10 grams. 
indications for use. cattle fed in confinement for slaughter: for prevention and control of coccidiosis due to e. bovis and e. zuernii ; and reduction of incidence of liver abscesses caused by fusobacterium necrophorum and arcanobacterium (actinomyces) pyogenes. 
limitations. feed only to cattle being fed in confinement for slaughter. for prevention and control of coccidiosis, feed at a rate of 0.14 to 0.42 milligrams monensin per pound of body weight per day, depending upon the severity of challenge, up to maximum of 480 milligrams per head per day; and 60 to 90 milligrams of tylosin per head per day. tylosin provided by nos. 000986 and 016592 in  510.600(c) of this chapter. 
(xiii) amount per ton. monensin, 11 to 22 grams. 
(a) indications for use. for increased milk production efficiency (production of marketable solids-corrected milk per unit of feed intake) in dairy cows. 
(b) limitations. feed continuously to dry and lactating dairy cows in a total mixed ration (complete feed). see special labeling considerations in paragraph (d) of this section. 
(xiv) amount per ton. monensin, 11 to 400 grams. 
(a) indications for use. for increased milk production efficiency (production of marketable solids-corrected milk per unit of feed intake) in dairy cows. 
(b) limitations. feed continuously to dry and lactating dairy cows in a component feeding system (including top dress). the type c medicated feed must be fed in a minimum of 1 lb of feed to provide 185 to 660 mg/head/day monensin to lactating cows or 115 to 410 mg/head/day monensin to dry cows. see special labeling considerations in paragraph (d) of this section. 
(4) replacement chickens intended for use as cage layers (i) amount per ton. monensin, 90 to 110 grams. 
(i)( indications for use. as an aid in the prevention of coccidiosis caused by e. necatrix, e. tenella, e. acervulina, e. brunetti, e. mivati, and e. maxima. 
(ii) amount per ton. monensin, 90 to 110 grams; plus bacitracin methylene disalicylate, 4 to 50 grams. 
indications for use. as an aid in the prevention of coccidiosis caused by e. necatrix, e. tenella, e. acervulina, e. brunetti, e. mivati, and e. maxima ; for increased rate of weight gain, and improved feed efficiency. 
limitations. feed continuously as sole ration. do not feed to chickens over 16 weeks of age. do not feed to laying chickens. as monensin sodium provided by 000986; bacitracin methylene disalicylate as provided by 054771 in  510.600(c) of this chapter. 
(iii) amount per ton. monensin, 90 to 110 grams; plus bacitracin methylene disalicylate, 50 grams. 
indications for use. as an aid in the prevention of coccidiosis caused by e. necatrix, e. tenella, e. acervulina, e. brunetti, e. mivati, and e. maxima ; and as an aid in the prevention of necrotic enteritis caused or complicated by clostridium spp. or other organisms susceptible to bacitracin. 
limitations. feed continuously as sole ration. do not feed to chickens over 16 weeks of age. do not feed to laying chickens. as monensin sodium provided by 000986; bacitracin methylene disalicylate as provided by 054771 in  510.600(c) of this chapter. 
(iv) limitations. do not feed to laying chickens; feed continuously as sole ration; as monensin sodium; do not feed to chickens over 16 weeks of age. 
(v) amount per ton. monensin, 90 to 110 grams; plus bacitracin methylene disalicylate, 100 to 200 grams. 
indications for use. as an aid in the prevention of coccidiosis caused by e. necatrix, e. tenella, e. acervulina, e. brunetti, e. mivati, and e. maxima ; and as an aid in the control of necrotic enteritis caused or complicated by clostridium spp. or other organisms susceptible to bacitracin. 
limitations. feed continuously as sole ration. do not feed to chickens over 16 weeks of age. do not feed to laying chickens. to control necrotic enteritis, start medication at first clinical signs of disease; vary dosage based on the severity of infection; administer continuously for 5 to 7 days or as long as clinical signs persist, then reduce bacitracin to prevention level (50 grams per ton). as monensin sodium provided by 000986; bacitracin methylene disalicylate as provided by 054771 in  510.600(c) of this chapter. 
(vi)-(vii) [reserved] 
(5) bobwhite quail (i) amount per ton. monensin, 73 grams. 
(ii) indications for use. for the prevention of coccidiosis in growing bobwhite quail caused by eimeria dispersa and e. lettyae. 
(iii) limitations. feed continuously as the sole ration; do not allow horses, other equines, mature turkeys, or guinea fowl access to feed containing monensin. 
(6) goats (i) amount per ton. monensin, 20 grams. 
indications for use. for the prevention of coccidiosis caused by eimeria crandallis, e. christenseni, and e. ninakohlyakimovae. 
limitations ( feed continuously. feed only to goats being fed in confinement. do not feed to lactating goats. type c feeds may be manufactured from monensin liquid type b feeds. the liquid type b feeds have a ph of 4.3 to 7.1 and their labels must bear appropriate mixing directions, as defined in paragraph (d)(12) of this section. see special labeling considerations in paragraph (d) of this section. 
) an approved physically stable monensin liquid feed will not be subject to the requirements for mixing directions defined in paragraph (d)12) of this section. a manufacturer may secure approval of a physically stable liquid feed by: 
) either filing an nada for the product or by establishing a master file containing data to support the stability of its product; 
ii ) authorizing the agency to reference and rely upon the data in the master file to support approval of a supplemental nada to establish physical stability; and 
iii ) requesting no. 000986 in  510.600(c) of this chapter to file a supplemental nada to provide for the use of its monensin type a article in the manufacture of the liquid feed specified in the appropriate master file. if the data demonstrate the stability of the liquid feed described in the master file, the agency will approve the supplemental nada. the approval will provide a basis for the individual liquid feed manufacturer to manufacture the liquid medicated feed under a medicated feed mill license described in the master file. a manufacturer who seeks to market a physically unstable monensin liquid feed with mixing directions different from the standard established in paragraph (d)(12) of this section may also follow this procedure. 
(ii) [reserved] 
(7) free-choice feeds (i) amount. 150 milligrams per pound of protein-mineral block (0.033 percent). 
) [reserved] 
conditions of use ( indications for use. for increased rate of weight gain; and for prevention and control of coccidiosis caused by eimeria bovis and e. zuernii in pasture cattle (slaughter, stocker, feeder, and dairy and beef replacement heifers) which may require supplemental feed. 
limitations. provide 50 to 200 milligrams of monensin (0.34 to 1.33 pounds of block) per head per day, at least 1 block per 10 to 12 head of cattle. roughage must be available at all times. do not allow animals access to other protein blocks, salt or mineral, while being fed this product. the effectiveness of this block in cull cows and bulls has not been established. see paragraph (d)(10)(i) of this section. 
(ii) amount. 400 milligrams per pound of protein-mineral block (0.088 percent). 
sponsor. see no. 067949 in  510.600(c) of this chapter. 
conditions of use ( indications for use. for increased rate of weight gain in pasture cattle (slaughter, stocker, feeder, and dairy and beef replacement heifers). 
limitations. provide 80 to 200 milligrams of monensin (0.2 to 0.5 pounds of block) per head per day, at least 1 block per 5 head of cattle. feed blocks continuously. do not feed salt or minerals containing salt. the effectiveness of this block in cull cows and bulls has not been established. see paragraph (d)(10)(i) of this section. 
(iii) amount. 175 milligrams per pound of protein-mineral block (0.038 percent). 
sponsor. see no. 017800 in  510.600(c) of this chapter. 
conditions of use ( indications for use. for increased rate of weight gain in pasture cattle (slaughter, stocker, and feeder). 
limitations. provide 40 to 200 milligrams of monensin (0.25 to 1.13 pounds or 4 to 18 ounces of block) per head per day, at least 1 block per 4 head of cattle. do not allow cattle access to salt or mineral while being fed this product. ingestion by cattle of monensin at levels of 600 milligrams per head per day and higher has been fatal. the effectiveness of this block in cull cows and bulls has not been established. see paragraph (d)(10)(i) of this section. 
(iv) amount. 400 milligrams per pound of block (0.088 percent). 
sponsor. see no. 051267 in  510.600(c) of this chapter. 
conditions of use ( indications for use. for increased rate of weight gain in pasture cattle (slaughter, stocker, feeder, and dairy and beef replacement heifers). 
limitations. provide 50 to 200 milligrams of monensin (2 to 8 ounces of block) per head per day, at least 1 block per 5 head of cattle. feed blocks continuously. do not feed salt or mineral supplements in addition to the blocks. ingestion by cattle of monensin at levels of 600 milligrams per head per day and higher has been fatal. the effectiveness of this block in cull cows and bulls has not been established. see paragraph (d)(10)(i) of this section. 
(8) monensin may also be used in combination with: 
(i) decoquinate alone or with tylosin as in  558.195. 
(ii) melengestrol acetate alone or with tylosin as in  558.342. 
(iii) ractopamine alone or in combination as in  558.500. 
(iv) tilmicosin alone or in combination as in  558.618. 
(v) zilpaterol alone or in combination as in  558.665. 

editorial notes: 1. for federal register citations affecting  558.355, see the list of cfr sections affected, which appears in the finding aids section of the printed volume and at www.fdsys.gov. 2. at 79 fr 13545, mar. 11, 2014,  558.355 was amended; however, the amendments to (f)(1)(vii)( ) and (f)(4)(iv)( ) could not be incorporated because those paragraphs did not exist.", 
